NASDAQ: SHOTSafety Shot Inc Stock
$0.43-0.02 (-4.44%)
Updated Mar 27, 2025
SHOT Price
$0.43
Fair Value Price
-$0.37
Market Cap
$26.47M
52 Week Low
$0.41
52 Week High
$2.46
P/E
-0.51x
P/B
4.15x
P/S
60.71x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.12M
Earnings
-$41.56M
Gross Margin
-208.7%
Operating Margin
-3,674.78%
Profit Margin
-3,697.4%
Debt to Equity
0.31
Operating Cash Flow
-$23M
Beta
0.84
Next Earnings
May 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SHOT Overview
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. It also manufactures consumer products such as CBD-infused sunscreen under the CaniSun brand, CBD-infused skin care lotion under the CaniSkin brand, and products for dermatological treatment of pain and inflammation under the CaniDermRX brand. Jupiter Wellness was incorporated in 2018 and is headquartered in Jupiter, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SHOT's potential to beat the market
- SHOT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Beverage
Industry Rating
B
SHOT
RankedUnranked of 15
RankedUnranked of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.37 | A | |
| $1,315.00 | A | |
| $91.21 | B |
Be the first to know about important SHOT news, forecast changes, insider trades & much more!
SHOT News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SHOT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SHOT ($0.43) is overvalued by 216.9% relative to our estimate of its Fair Value price of -$0.37 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SHOT ($0.43) is not significantly undervalued (216.9%) relative to our estimate of its Fair Value price of -$0.37 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SHOT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SHOT due diligence checks available for Premium users.
Valuation
SHOT fair value
Fair Value of SHOT stock based on Discounted Cash Flow (DCF)
Price
$0.43
Fair Value
-$0.37
Undervalued by
216.09%
SHOT ($0.43) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SHOT ($0.43) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SHOT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SHOT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.51x
Industry
17.87x
Market
31.08x
SHOT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.15x
Industry
7.37x
SHOT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SHOT's financial health
Profit margin
Revenue
$110.2k
Net Income
-$11.9M
Profit Margin
-10,823.8%
SHOT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SHOT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.4M
Liabilities
$2.0M
Debt to equity
0.31
SHOT's short-term assets ($3.48M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SHOT's short-term assets ($3.48M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SHOT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.1M
Investing
-$632.6k
Financing
$4.2M
SHOT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SHOT vs Beverage Stocks
Safety Shot Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.